Bellerophon Therapeutics (BLPH) Tops Q1 EPS by 11c

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q1 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• ACRES Commercial Realty says labor dispute is hindering hotel sale
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick